Evidence map›Paper›PMID 31378711›Full record

ArticleCell chemical biology2019

A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery.

Elizabeth A McMillan, Gino Kwon, Jean R Clemenceau, Kurt W Fisher, Rachel M Vaden, Anam F Shaikh, Beth K Neilsen, David Kelly, Malia B Potts, Yeo-Jin Sung and 7 more

Abstract read
In one paragraph

Article in Cell chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Modulation ofJournal of natural products · 2023
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Elizabeth A McMillanDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Gino KwonGraduate Program for Nanomedical Science, Yonsei University, Seoul, Korea.
Jean R ClemenceauDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Kurt W FisherDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Rachel M VadenDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Anam F ShaikhDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Beth K NeilsenEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
David KellyEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Malia B PottsDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Yeo-Jin SungSeverance Biomedical Science Institute, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Saurabh MendirattaDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Suzie K HightDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Yunji LeeSeverance Biomedical Science Institute, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
John B MacMillanDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA 95064, USA. Electronic address: jomacmil@ucsd.edu.
Robert E LewisEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: rlewis@unmc.edu.
Hyun Seok KimSeverance Biomedical Science Institute, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea; Graduate Program for Nanomedical Science, Yonsei University, Seoul, Korea. Electronic address: hsfkim@yuhs.ac.
Michael A WhiteDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: michael.a.white@pfizer.com.

Funding

Urgent Covid-19 Revision to the Center for High-Throughput Functional Annotation of Natural ProductsU41AT008718 · NCCIH · UT SOUTHWESTERN MEDICAL CENTER · PI CECH, NADJA B, LININGTON, ROGER G · 2015 to 2024
$10.1M
DIVISION OF CELL &MOLECULAR BIOLOGY TRAINING PROGRAMT32GM008203 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1987 to 2018
$7.0M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
Cancer Biology Training GrantT32CA124334 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 2007 to 2021
$5.3M
The role of PGC1beta and ERRalpha as novel targets for therapy in colorectal cancerK08CA222887 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FISHER, KURT · 2018 to 2022
$1.2M
NCCIH NIH HHS U41 AT008718NCI NIH HHS K08 CA222887NCI NIH HHS T32 CA009476NCI NIH HHS T32 CA124334NIGMS NIH HHS T32 GM008203
6 · The paper itself

Abstract

Gene expression signature-based inference of functional connectivity within and between genetic perturbations, chemical perturbations, and disease status can lead to the development of actionable hypotheses for gene function, chemical modes of action, and disease treatment strategies. Here, we report a FuSiOn-based genome-wide integration of hypomorphic cellular phenotypes that enables functional annotation of gene network topology, assignment of mechanistic hypotheses to genes of unknown function, and detection of cooperativity among cell regulatory systems. Dovetailing genetic perturbation data with chemical perturbation phenotypes allowed simultaneous generation of mechanism of action hypotheses for thousands of uncharacterized natural products fractions (NPFs). The predicted mechanism of actions span a broad spectrum of cellular mechanisms, many of which are not currently recognized as "druggable." To enable use of FuSiOn as a hypothesis generation resource, all associations and analyses are available within an open source web-based GUI (http://fusion.yuhs.ac).

Indexed as

Drug DiscoverySoftwareBiological ProductsHCT116 CellsHeLa CellsHumansNeoplasmsPhenotypeTranscriptomeTumor Cells, CulturedBiological Productscell regulatory networkschemical geneticsfunctional genomicsmechanism of actionnatural productsnetwork pharmacology

Identifiers

PMID31378711
PMCPMC9161285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.